180 related articles for article (PubMed ID: 29863220)
1. Population-Based Analysis of Patient Age and Other Disparities in the Treatment of Ovarian Cancer in Central Appalachia and Kentucky.
Ore RM; Chen Q; DeSimone CP; Miller RW; Baldwin LA; van Nagell JR; Huang B; Tucker TC; Johnson MS; Fredericks TI; Ueland FR
South Med J; 2018 Jun; 111(6):333-341. PubMed ID: 29863220
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.
Hodeib M; Chang J; Liu F; Ziogas A; Dilley S; Randall LM; Anton-Culver H; Bristow RE
Gynecol Oncol; 2015 Jul; 138(1):121-7. PubMed ID: 25913132
[TBL] [Abstract][Full Text] [Related]
3. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
[TBL] [Abstract][Full Text] [Related]
4. Development of Multiple Primary Cancers in Lung Cancer Patients: Appalachian Versus Non-Appalachian Populations of Kentucky.
Pravosud V; Huang B; Tucker T; Vanderford NL
South Med J; 2017 Dec; 110(12):775-781. PubMed ID: 29197312
[TBL] [Abstract][Full Text] [Related]
5. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
[TBL] [Abstract][Full Text] [Related]
6. Compliance with gastric cancer guidelines is associated with improved outcomes.
Worhunsky DJ; Ma Y; Zak Y; Poultsides GA; Norton JA; Rhoads KF; Visser BC
J Natl Compr Canc Netw; 2015 Mar; 13(3):319-25. PubMed ID: 25736009
[TBL] [Abstract][Full Text] [Related]
7. Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
Bristow RE; Chang J; Ziogas A; Anton-Culver H
Obstet Gynecol; 2013 Jun; 121(6):1226-1234. PubMed ID: 23812456
[TBL] [Abstract][Full Text] [Related]
8. Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center.
Erickson BK; Martin JY; Shah MM; Straughn JM; Leath CA
Gynecol Oncol; 2014 May; 133(2):142-6. PubMed ID: 24517876
[TBL] [Abstract][Full Text] [Related]
9. Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.
Bristow RE; Chang J; Ziogas A; Anton-Culver H; Vieira VM
Gynecol Oncol; 2014 Jul; 134(1):60-7. PubMed ID: 24680770
[TBL] [Abstract][Full Text] [Related]
10. Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes.
Visser BC; Ma Y; Zak Y; Poultsides GA; Norton JA; Rhoads KF
HPB (Oxford); 2012 Aug; 14(8):539-47. PubMed ID: 22762402
[TBL] [Abstract][Full Text] [Related]
11. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
12. Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention.
Dottino JA; Cliby WA; Myers ER; Bristow RE; Havrilesky LJ
Gynecol Oncol; 2015 Sep; 138(3):694-9. PubMed ID: 26072441
[TBL] [Abstract][Full Text] [Related]
13. Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer.
Aviki EM; Lavery JA; Roche KL; Cowan R; Dessources K; Basaran D; Green AK; Aghajanian CA; O'Cearbhaill R; Jewell EL; Leitao MM; Gardner GJ; Abu-Rustum NR; Sabbatini P; Bach PB
Gynecol Oncol; 2020 Nov; 159(2):418-425. PubMed ID: 32814642
[TBL] [Abstract][Full Text] [Related]
14. Nonadherence to Standard of Care for Locally Advanced Colon Cancer as a Contributory Factor for High Mortality Rates in Kentucky.
Chow Z; Gan T; Chen Q; Huang B; Schoenberg N; Dignan M; Evers BM; Bhakta AS
J Am Coll Surg; 2020 Apr; 230(4):428-439. PubMed ID: 32062006
[TBL] [Abstract][Full Text] [Related]
15. Refusal of Recommended Chemotherapy for Ovarian Cancer: Risk Factors and Outcomes; a National Cancer Data Base Study.
Wallace SK; Lin JF; Cliby WA; Leiserowitz GS; Tergas AI; Bristow RE
J Natl Compr Canc Netw; 2016 May; 14(5):539-50. PubMed ID: 27160232
[TBL] [Abstract][Full Text] [Related]
16. Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.
Tan X; Camacho F; Marshall VD; Donohoe J; Anderson RT; Balkrishnan R
Res Social Adm Pharm; 2017; 13(4):796-810. PubMed ID: 27641308
[TBL] [Abstract][Full Text] [Related]
17. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for laryngeal cancer.
Swegal WC; Herbert RJ; Eisele DW; Chang J; Bristow RE; Gourin CG
Laryngoscope; 2020 Mar; 130(3):672-678. PubMed ID: 31169916
[TBL] [Abstract][Full Text] [Related]
18. Gynecologic cancer in HIV-infected women: treatment and outcomes in a multi-institutional cohort.
Levinson KL; Riedel DJ; Ojalvo LS; Chan W; Angarita AM; Fader AN; Rositch AF
AIDS; 2018 Jan; 32(2):171-177. PubMed ID: 29028665
[TBL] [Abstract][Full Text] [Related]
19. The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer.
Urban RR; He H; Alfonso-Cristancho R; Hardesty MM; Goff BA
J Natl Compr Canc Netw; 2016 Apr; 14(4):429-37. PubMed ID: 27059191
[TBL] [Abstract][Full Text] [Related]
20. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.
Galvan-Turner VB; Chang J; Ziogas A; Bristow RE
Gynecol Oncol; 2015 Dec; 139(3):495-9. PubMed ID: 26387962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]